184 related articles for article (PubMed ID: 16538881)
1. Long-term clinical experience with pure bicarbonate peritoneal dialysis solutions.
Montenegro J; Saracho RM; Martínez IM; Muñoz RI; Ocharan JJ; Valladares E
Perit Dial Int; 2006; 26(1):89-94. PubMed ID: 16538881
[TBL] [Abstract][Full Text] [Related]
2. An amino acid-based peritoneal dialysis fluid buffered with bicarbonate versus glucose/bicarbonate and glucose/lactate solutions: an intraindividual randomized study.
Plum J; Erren C; Fieseler C; Kirchgessner J; Passlick-Deetjen J; Grabensee B
Perit Dial Int; 1999; 19(5):418-28. PubMed ID: 11379854
[TBL] [Abstract][Full Text] [Related]
3. Clinical experience with a new bicarbonate (25 mmol/L)/lactate (10 mmol/L) peritoneal dialysis solution.
Otte K; Gonzalez MT; Bajo MA; del Peso G; Heaf J; Garcia Erauzkin G; Sanchez Tomero JA; Dieperink H; Povlsen J; Hopwood AM; Divino Filho JC; Faict D
Perit Dial Int; 2003; 23(2):138-45. PubMed ID: 12713080
[TBL] [Abstract][Full Text] [Related]
4. A long-term study of a bicarbonate/lactate-based peritoneal dialysis solution--clinical benefits. The Bicarbonate/Lactate Study Group.
Tranaeus A
Perit Dial Int; 2000; 20(5):516-23. PubMed ID: 11117242
[TBL] [Abstract][Full Text] [Related]
5. Acidosis correction with a new 25 mmol/l bicarbonate/15 mmol/l lactate peritoneal dialysis solution.
Carrasco AM; Rubio MA; Sanchez Tommero JA; Fernandez Girón F; Gonzalez Rico M; del Peso Gilsanz G; Fernandez Perpén A; Ramón RG; Bueno IF; Tranaeus A; Faict D; Hopwood A
Perit Dial Int; 2001; 21(6):546-53. PubMed ID: 11783762
[TBL] [Abstract][Full Text] [Related]
6. In vivo and in vitro effects of amino-acid-based and bicarbonate-buffered peritoneal dialysis solutions with regard to peritoneal transport and cytokines/prostanoids dialysate concentrations.
Plum J; Fusshöller A; Schoenicke G; Busch T; Erren C; Fieseler C; Kirchgessner J; Passlick-Deetjen J; Grabensee B
Nephrol Dial Transplant; 1997 Aug; 12(8):1652-60. PubMed ID: 9269644
[TBL] [Abstract][Full Text] [Related]
7. Individualized bicarbonate concentrations in the peritoneal dialysis fluid to optimize acid-base status in CAPD patients.
Feriani M; Passlick-Deetjen J; Jaeckle-Meyer I; La Greca G;
Nephrol Dial Transplant; 2004 Jan; 19(1):195-202. PubMed ID: 14671057
[TBL] [Abstract][Full Text] [Related]
8. Comparison between bicarbonate/lactate and standard lactate dialysis solution in peritoneal transport and ultrafiltration: a prospective, crossover single-dwell study.
Fang W; Mullan R; Shah H; Mujais S; Bargman JM; Oreopoulos DG
Perit Dial Int; 2008; 28(1):35-43. PubMed ID: 18178946
[TBL] [Abstract][Full Text] [Related]
9. Effects of ionized sodium concentrations on ultrafiltration rate in peritoneal dialysis using lactate and lactate/bicarbonate solutions.
La Milia V; Limardo M; Crepaldi M; Locatelli F
Perit Dial Int; 2009; 29(2):158-62. PubMed ID: 19293352
[TBL] [Abstract][Full Text] [Related]
10. Acid-base profile and predictors of metabolic acidosis in patients undergoing peritoneal dialysis with lactate- and bicarbonate-buffered peritoneal dialysis solutions.
Fourtounas C; Savidaki E; Roumelioti M; Dousdampanis P; Hardalias A; Kalliakmani P; Papachristou E; Drakopoulos A; Goumenos DS; Vlachojannis JG
Adv Perit Dial; 2006; 22():187-91. PubMed ID: 16983967
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience with two physiologic bicarbonate/lactate peritoneal dialysis solutions in automated peritoneal dialysis.
Dratwa M; Wilkie M; Ryckelynck JP; ter Wee PM; Rutherford P; Michel C; Hopwood A; Curtis L; Denys N; Divino Filho JC; Faict D;
Kidney Int Suppl; 2003 Dec; (88):S105-13. PubMed ID: 14870884
[TBL] [Abstract][Full Text] [Related]
12. Effect of bicarbonate/lactate peritoneal dialysis solutions on human mesothelial cell proliferation ex vivo.
Bajo MA; del Peso G; Castro MA; Díaz C; Castro MJ; Gil F; Sánchez-Tomero JA; Selgas R
Adv Perit Dial; 2001; 17():37-41. PubMed ID: 11510293
[TBL] [Abstract][Full Text] [Related]
13. Improved acidosis correction and recovery of mesothelial cell mass with neutral-pH bicarbonate dialysis solution among children undergoing automated peritoneal dialysis.
Haas S; Schmitt CP; Arbeiter K; Bonzel KE; Fischbach M; John U; Pieper AK; Schaub TP; Passlick-Deetjen J; Mehls O; Schaefer F
J Am Soc Nephrol; 2003 Oct; 14(10):2632-8. PubMed ID: 14514742
[TBL] [Abstract][Full Text] [Related]
14. Randomized long-term evaluation of bicarbonate-buffered CAPD solution.
Feriani M; Kirchgessner J; La Greca G; Passlick-Deetjen J
Kidney Int; 1998 Nov; 54(5):1731-8. PubMed ID: 9844152
[TBL] [Abstract][Full Text] [Related]
15. Generation of TNFalpha and interleukin-6 by peritoneal macrophages after overnight dwells with bicarbonate- or lactate-buffered dialysis fluid.
Liberek T; Lichodziejewska-Niemierko M; Knopinska-Posluszny W; Schaub TP; Kirchgessner J; Passlick-Deetjen J; Rutkowski B
Perit Dial Int; 2002; 22(6):663-9. PubMed ID: 12556067
[TBL] [Abstract][Full Text] [Related]
16. Bicarbonate/lactate dialysis solution improves in vivo function of peritoneal host defense in rats.
Pawlaczyk K; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Polubinska A; Wisniewska J; Faict D; Holmes CJ; Breborowicz A
Perit Dial Int; 1999; 19 Suppl 2():S370-7. PubMed ID: 10406549
[TBL] [Abstract][Full Text] [Related]
17. Short-term effects of a new bicarbonate/lactate-buffered and conventional peritoneal dialysis fluid on peritoneal and systemic inflammation in CAPD patients: a randomized controlled study.
Pajek J; Kveder R; Bren A; Gucek A; Ihan A; Osredkar J; Lindholm B
Perit Dial Int; 2008; 28(1):44-52. PubMed ID: 18178947
[TBL] [Abstract][Full Text] [Related]
18. Biocompatible peritoneal dialysis solutions: do they indeed affect the outcome?
Grzegorzewska AE
Pol Arch Med Wewn; 2009 Apr; 119(4):242-7. PubMed ID: 19413184
[TBL] [Abstract][Full Text] [Related]
19. Effects of pH-neutral, bicarbonate-buffered dialysis fluid on peritoneal transport kinetics in children.
Schmitt CP; Haraldsson B; Doetschmann R; Zimmering M; Greiner C; Böswald M; Klaus G; Passlick-Deetjen J; Schaefer F
Kidney Int; 2002 Apr; 61(4):1527-36. PubMed ID: 11918761
[TBL] [Abstract][Full Text] [Related]
20. Effects of Conversion to a Bicarbonate/Lactate-Buffered, Neutral-pH, Low-GDP PD Regimen in Prevalent PD: A 2-Year Randomized Clinical Trial.
Farhat K; Douma CE; Ferrantelli E; Ter Wee PM; Beelen RHJ; van Ittersum FJ
Perit Dial Int; 2017; 37(3):273-282. PubMed ID: 28348100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
